Celltrion Healthcare Co. Ltd. has successfully completed a KRW1tn ($889.3m) IPO in South Korea's second-tier Kosdaq market, paving the way for the company to further expand its global sales networks and product portfolios.
Celltrion Healthcare, which is the global marketing and distribution arm of Celltrion Inc., has exclusive sales rights to Celltrion's...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

